Granulocyte-colony stimulating factors (G-CSFs) reduce the risk of febrile neutropenia in patients with cancer. This study evaluates the clinical and nonclinical value associated with G-CSFs. Given ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results